Victrex
Develops high-performance PEEK and PAEK polymers, filaments, and powders optimized for additive manufacturing, enabling metal replacement in aerospace, medical, and automotive applications.
- CEO / Founder
- James Routh
- Team Size
- 1001-5000
- Stage
- Public
- Total Funding
- Publicly Traded
- Latest Round
- IPO
- Key Investors
- CVC Capital Partners; Cinven
Technology & Products
Key Products
Victrex offers a full range of PEEK and PAEK polymers, filaments, and powders. Their product portfolio includes composite solutions, gear solutions, medical device components, and pipe solutions, serving industries such as aerospace, medical, and automotive.
Technological Advantage
CLAIMED: Industry-leading mechanical properties and thermal stability for 3D printed PAEK parts. VERIFIED: Validated by partnerships with Bond 3D and INTAMSYS; extensive third-party testing and aerospace/medical certifications. DEFENSIBLE: Protected by decades of proprietary polymerization patents and trade secrets in AM-grade formulation.
Patent position
Victrex filed 3 patent families in 2022-2024 versus 10 in 2019-2021, a 70% fall that far outpaces the 21% decline in tracked AM filings across the same patent offices, and its 17-family total trails far behind Arkema (132) and Stratasys (494). AMPulse analysis
- Filing momentum
- 3 families filed 2022–2024, 10 in 2019–2021 (-70%); all tracked AM filings in the same offices -21%
- Filed in
- EP 41%US 29%CN 24%WO 12%
- Named competitors, AM patent families
- Arkema 132Sintavia 3Stratasys 494
17 AM patent families in total. Recent years are still being published, so read a filing change against the same-office figure.
Differentiation
Value Proposition
Reduces component weight by up to 60% versus metal while maintaining mechanical performance, cutting lead times and enabling complex geometries for end-use parts in extreme environments.
How They Differentiate
Unlike broad chemical conglomerates, Victrex exclusively focuses on PAEK, offering vertically integrated AM material development with dedicated process validation centers. Achieves higher crystallinity control and interlayer adhesion in FDM/SLS processes compared to standard industrial PEEK grades.
Market & Competition
Target Customers
OEMs and tier suppliers in aerospace, medical, automotive, and industrial sectors requiring high-strength, heat-resistant 3D printed components.
Industry Verticals
Aerospace & Defense; Medical; Automotive; Energy & Industrial; Electronics
Competitors
Solvay, BASF, Arkema, Elementis, Scapa Group, Essentra, Sintavia, Origin Materials, Stratasys
Growth & Milestones
Growth Metrics
FY2025: sales volumes +12% YoY; group revenue £292.7m (~$370M). H1 2026: revenue £147.1m (+1% YoY), volumes 2,137t (+6%). Q3 2026 trading: stronger volume/revenue growth vs prior year (company trading update 7 Jul 2026).
Major Milestones
Listed on London Stock Exchange (LSE: VCT); Launched VICTREX AM 200 PAEK filament (2020); Opened Polymer Innovation Centre in Thornton-Cleveleys; Commenced commercial PEEK manufacturing in China (2024)
Notable Customers
Victrex serves customers in aerospace (20,000+ aircraft flying with Victrex solutions), automotive (500 million+ PEEK applications in cars), energy (75+ million Victrex PEEK applications), and medical (Invibio division).
AM patents
AM-relevant patents linked to this company.
- Patents
- 18
- Granted
- 7
- Families
- 17
Leading domains: process (18), material (14), equipment (8)
Filings by year: 2022: 3 · 2020: 8 · 2019: 2 · 2015: 2 · 2014: 3
- FILAMENT FOR ADDITIVE MANUFACTURING AND PROCESS FOR MAKING THE SAME2021205159 · WO
- A COMPONENT AND METHOD OF FORMATION OF A COMPONENT04619214 · EP
- COPOLYMERS, PREPARATION AND USE THEREOF116157471 · CN
- Polymeric material, manufacture and use12110363 · US
- POLYMERIC MATERIALS3705272 · EP
Funding rounds
- IPOUndisclosed1995-01Source: London Stock Exchange, Victrex official history
- Management BuyoutUndisclosed1993-01Source: Victrex official history, Wikipedia, PESTEL Analysis